R&D and Quality
Liposomal targeted delivery, Liposomic - connecting cellular absorption with metabolism
Liposomal delivery can improve a drug’s biodistribution, increase its therapeutic index, and potentially reduce side effects.In the context of nutrition and metabolism, liposomic delivery systems protect sensitive nutrients (e.g., polyphenols, omega-3 fatty acids, vitamins, probiotics, and peptides) from gastrointestinal degradation and promote their transport across cellular barriers like the intestinal epithelium. This targeted absorption enhances metabolic signaling pathways, influences mitochondrial function, supports antioxidant responses, and modulates lipid and glucose metabolism. Additionally, surface modification with ligands such as antibodies, peptides, or glycoproteins enables precision targeting to specific tissues or metabolic pathways—for example, delivering nutrients preferentially to hepatocytes, adipocytes, or immune cells. Metabolomics is used to identify how a nutrient alters a cell’s metabolic pathways and other cellular processes, providing insights into its efficacy and side effects.
Microbial therapeutics - precision biotics approach. Prebiotic, probiotics and postbiotics.
Microbial therapeutics represent a rapidly expanding field focused on modulating the gut microbiome to improve host health and treat disease.
Prebiotics are selectively fermented substrates that stimulate the growth and metabolic activity of beneficial microorganisms, whereas probiotics introduce live microbial strains capable of restoring microbial balance and enhancing functional outputs of the gut ecosystem.
Postbiotics, comprising microbial metabolites and cell components, provide defined biological activities without the challenges associated with live-cell delivery.
Precision biotics means using detailed knowledge of an individual’s microbiome, metabolomic and immune status to pick and combine a specific prebiotic + probiotic + postbiotic set that will optimally drive the desired host-microbiome interaction and therapeutic outcome.
We use data driven approach to select ,formulate and deploy probiotics, based on individual microbiome,omics profile,life style and clinical parameter.
Developing science-based proprietary products that sit at the interface of food and pharmaceuticals, Camillotek ideally poised to exploit an immense multi-tiered commercial opportunity.
Backward integration from Seed to Shelf
Raw Material Supply Evaluation
Over 100+ quality checks performed on raw materials using accredited, third-party labs to ensure purity, potency & safety.
Delayed Release Capsulation
An innovation in delivery system for effective product performance must for probiotics, enzymes and highly purified ingredients sensitive to stomach acids.
QUALTIY ASSURANCE
ISO 9001:2015 Quality Management System
WHO-GMP – Good Manufacturing Practice
Fssai – Food Safety Standards India
GMP – Local Health Authority
Intellectual Property
